19088 Federal Register / Vol. 80, No. 68 / Thursday, April 9, 2015 / Notices 

(http://www.fda.gov/ScienceResearch/

SpecialTopics/RegulatoryScience/

ucm267719.htm). 

Date and Time: The public workshop 

will be held on May 27, 2015, from 8:30 

a.m. to 3:45 p.m. and May 28, 2015, 

from 8:30 a.m. to 4 p.m. 

Location: The public workshop will 

be held at FDA White Oak Campus, 

10903 New Hampshire Ave., Building 

31 Conference Center, the Great Room 

(Rm. 1503), Silver Spring, MD 20993– 

0002. Entrance for the public workshop 

participants (non-FDA employees) is 

through Building 1 where routine 

security check procedures will be 

performed. For parking and security 

information, please refer to http://

www.fda.gov/AboutFDA/

WorkingatFDA/BuildingsandFacilities/

WhiteOakCampusInformation/

ucm241740.htm. 

Contact Person: Leslie Wheelock, 

Office of Scientific Professional 

Development, Office of the Chief 

Scientist, Office of the Commissioner, 

Food and Drug Administration, 10903 

New Hampshire Ave., Bldg. 1, Rm. 

4345, Silver Spring, MD, 301–796–4580, 

FAX: 301–847–8106, email: 

FDASciProDev@fda.hhs.gov. 

Registration: Submit your online 

registration information (including 

name, title, firm name, address, 

telephone and email) by May 15, 2015 

at: http://www.fda.gov/scienceresearch/

aboutscienceresearchatfda/

ucm429403.htm. 

There is no registration fee for the 

public workshop. Early registration is 

recommended because seating is 

limited. There will be no onsite 

registration. 

If you need special accommodations 

due to a disability, please contact Leslie 

Wheelock (see Contact Person) at least 

7 days in advance. 

Webcast: Please be advised that as 

soon as possible after the Forum, a 

webcast and report of the public 

workshop will be accessible at: http://

www.fda.gov/scienceresearch/

aboutscienceresearchatfda/

ucm429403.htm. 

SUPPLEMENTARY INFORMATION: Each 

session of the FDA Science Forum will 

have an expert in the area and 

presentations by FDA staff. 

Dated: April 3, 2015. 

Leslie Kux, 

Associate Commissioner for Policy. 

[FR Doc. 2015–08156 Filed 4–8–15; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 552b(c) 

(4) and 552b(c) (6), title 5 U.S.C., as 

amended. The grant applications/ 

contract proposals and the discussions 

could disclose confidential trade secrets 

or commercial property such as 

patentable material, and personal 

information concerning individuals 

associated with the grant applications, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Outstanding Investigator Award 1. 

Date: April 29, 2015. 

Time: 1:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

6W030, Rockville, MD 20850, (Telephone 

Conference Call). 

Contact Person: Michael B. Small, Ph.D., 

Chief, Program and Review Extramural Staff 

Training Office, Division of Extramural 

Activities, National Cancer Institute, 9609 

Medical Center Drive, Room 7W522, 

Bethesda, MD 20892, 240–276–6438, 

smallm@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Targeted 

Radionuclide Therapy. 

Date: May 4, 2015. 

Time: 10:00 a.m. to 6:30 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W030, Rockville, MD 20850, (Telephone 

Conference Call). 

Contact Person: Thomas M. Vollberg, 

Ph.D., Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W102, Rockville, MD 20850, 

240–276–6341, vollbert@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI R01 

Review. 

Date: May 21, 2015. 

Time: 1:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W126, Rockville, MD 20850, (Telephone 

Conference Call). 

Contact Person: Caron A. Lyman, Ph.D., 

Chief, Scientific Review Officer, Research 

Programs Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W126, Bethesda, MD 20892–9750, 

240–276–6348, lymanc@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI SPORE 

Review. 

Date: June 8–9, 2015. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

Bethesda, MD 20852. 

Contact Person: Caterina Bianco, MD, 

Ph.D., Scientific Review Officer, Research 

Program Review Branch, Division Of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W116, Bethesda, MD 20892–9750, 

240–276–6459, biancoc@mail.nih.gov. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

deainfo.nci.nih.gov/advisory/sep/sep.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: April 3, 2015. 

Melanie J. Gray, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–08131 Filed 4–8–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 


Rmajette on DSK2VPTVN1PROD with NOTICES